This $9.5 Billion Takeover Offer Looks Too Good to Refuse, , on November 6, 2020 at 8:22 am

Financial News
By
On November 6, 2020
In Financial News
Tags:

(Bloomberg Opinion) — A takeover offer that would have been so-so in February becomes impossible to refuse for a company whose shares have been hit by the pandemic. The 7.2 billion-pound ($9.5 billion) approach for RSA Insurance Group has been shrewdly pitched by the Canadian-Danish consortium trying to buy the FTSE-100 insurer.RSA has been led by Stephen Hester since 2014. This particular chief executive role always seemed a little low profile for the former Credit Suisse Group AG investment banker, who previously took charge of Natwest Group Plc (then Royal Bank of Scotland) during the financial crisis. Few will be surprised that a good tenure would culminate in a deal.The 685 pence-a-share price mooted by Toronto-based insurer Intact Financial Corp. and Denmark’s Tryg A/S is a 51% premium over RSA’s three-month average. Ordinarily, such terms would be hard for a board to reject and RSA says the price is acceptable — although some of the details, notably funding the pension, need resolving to transform what is currently a proposal into a binding offer.Yet RSA shares have fallen sharply during the pandemic. That could provide some grounds for claiming the consortium is being opportunistic. The bid proposal is a less appealing 18% premium to where the shares were in February. All the same, that remains a good outcome for shareholders. The coronavirus’s impact cannot simply be imagined away: The bill for claims on business continuity insurance remains uncertain. Other takeover targets have had to fight to get bidders to meet even their pre-Covid share prices. The price here equates to 15 times next year’s expected earnings, a valuation the shares haven’t traded at since 2016.If a takeover on these terms looks like it’s worth more than the standalone option, the trickier question is whether there’s potentially a better alternative tie-up. RSA has long been talked of as a bid target. Zurich Insurance Group AG scrapped an attempted deal in 2015. RSA has remained independent because there aren’t many buyers who want its unusual bundle of U.K., Scandinavian and Canadian assets. Now that puzzle has been solved by bringing together a Canadian and Danish buyer in a joint bid, who would carve up the business between them.There are other theoretical combinations. RSA’s domestic peer Aviva Plc is retrenching internationally to focus on the U.K., Ireland and Canada. But it’s hard to see how it could assemble an offer on its own with a comparable premium, let alone 100% in cash as here. The big European insurers — Allianz SE, Axa SA and Zurich — may not have as much firepower as one would imagine. Allianz on Friday scrapped a share buyback to conserve capital. These usual suspects may hesitate to enter a public auction against a consortium with plausible synergy potential when the starting price is already high.RSA doesn’t have a firm deal yet. But at this level, it would be wise to dot the i’s and extract a binding offer here. And if there’s a better bid out there, let the market do the work of bringing it to the fore.This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Chris Hughes is a Bloomberg Opinion columnist covering deals. He previously worked for Reuters Breakingviews, as well as the Financial Times and the Independent newspaper.For more articles like this, please visit us at bloomberg.com/opinionSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.,

This $9.5 Billion Takeover Offer Looks Too Good to Refuse(Bloomberg Opinion) — A takeover offer that would have been so-so in February becomes impossible to refuse for a company whose shares have been hit by the pandemic. The 7.2 billion-pound ($9.5 billion) approach for RSA Insurance Group has been shrewdly pitched by the Canadian-Danish consortium trying to buy the FTSE-100 insurer.RSA has been led by Stephen Hester since 2014. This particular chief executive role always seemed a little low profile for the former Credit Suisse Group AG investment banker, who previously took charge of Natwest Group Plc (then Royal Bank of Scotland) during the financial crisis. Few will be surprised that a good tenure would culminate in a deal.The 685 pence-a-share price mooted by Toronto-based insurer Intact Financial Corp. and Denmark’s Tryg A/S is a 51% premium over RSA’s three-month average. Ordinarily, such terms would be hard for a board to reject and RSA says the price is acceptable — although some of the details, notably funding the pension, need resolving to transform what is currently a proposal into a binding offer.Yet RSA shares have fallen sharply during the pandemic. That could provide some grounds for claiming the consortium is being opportunistic. The bid proposal is a less appealing 18% premium to where the shares were in February. All the same, that remains a good outcome for shareholders. The coronavirus’s impact cannot simply be imagined away: The bill for claims on business continuity insurance remains uncertain. Other takeover targets have had to fight to get bidders to meet even their pre-Covid share prices. The price here equates to 15 times next year’s expected earnings, a valuation the shares haven’t traded at since 2016.If a takeover on these terms looks like it’s worth more than the standalone option, the trickier question is whether there’s potentially a better alternative tie-up. RSA has long been talked of as a bid target. Zurich Insurance Group AG scrapped an attempted deal in 2015. RSA has remained independent because there aren’t many buyers who want its unusual bundle of U.K., Scandinavian and Canadian assets. Now that puzzle has been solved by bringing together a Canadian and Danish buyer in a joint bid, who would carve up the business between them.There are other theoretical combinations. RSA’s domestic peer Aviva Plc is retrenching internationally to focus on the U.K., Ireland and Canada. But it’s hard to see how it could assemble an offer on its own with a comparable premium, let alone 100% in cash as here. The big European insurers — Allianz SE, Axa SA and Zurich — may not have as much firepower as one would imagine. Allianz on Friday scrapped a share buyback to conserve capital. These usual suspects may hesitate to enter a public auction against a consortium with plausible synergy potential when the starting price is already high.RSA doesn’t have a firm deal yet. But at this level, it would be wise to dot the i’s and extract a binding offer here. And if there’s a better bid out there, let the market do the work of bringing it to the fore.This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Chris Hughes is a Bloomberg Opinion columnist covering deals. He previously worked for Reuters Breakingviews, as well as the Financial Times and the Independent newspaper.For more articles like this, please visit us at bloomberg.com/opinionSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

,

Instant Quote

Enter the Stock Symbol.

Select the Exchange.

Select the Type of Security.

Please enter your First Name.

Please enter your Last Name.

Please enter your phone number.

Please enter your Email Address.

Please enter or select the Total Number of Shares you own.

Please enter or select the Desired Loan Amount you are seeking.

Please select the Loan Purpose.

Please select if you are an Officer/Director.

High West Capital Partners, LLC may only offer certain information to persons who are “Accredited Investors” and/or “Qualified Clients” as those terms are defined under applicable Federal Securities Laws. In order to be an “Accredited Investor” and/or a “Qualified Client”, you must meet the criteria identified in ONE OR MORE of the following categories/paragraphs numbered 1-20 below.

High West Capital Partners, LLC cannot provide you with any information regarding its Loan Programs or Investment Products unless you meet one or more of the following criteria. Furthermore, Foreign nationals who may be exempt from qualifying as a U.S. Accredited Investor are still required to meet the established criteria, in accordance with High West Capital Partners, LLC’s internal lending policies. High West Capital Partners, LLC will not provide information or lend to any individual and/or entity that does not meet one or more of the following criteria:

1) Individual with Net Worth in excess of $1.0 million. A natural person (not an entity) whose net worth, or joint net worth with his or her spouse, at the time of purchase exceeds $1,000,000 USD. (In calculating net worth, you may include your equity in personal property and real estate, including your principal residence, cash, short-term investments, stock and securities. Your inclusion of equity in personal property and real estate should be based on the fair market value of such property less debt secured by such property.)

2) Individual with $200,000 individual Annual Income. A natural person (not an entity) who had individual income of more than $200,000 in each of the preceding two calendar years, and has a reasonable expectation of reaching the same income level in the current year.

3) Individual with $300,000 Joint Annual Income. A natural person (not an entity) who had joint income with his or her spouse in excess of $300,000 in each of the preceding two calendar years, and has a reasonable expectation of reaching the same income level in the current year.

4) Corporations or Partnerships. A corporation, partnership, or similar entity that has in excess of $5 million of assets and was not formed for the specific purpose of acquiring an interest in the Corporation or Partnership.

5) Revocable Trust. A trust that is revocable by its grantors and each of whose grantors is an Accredited Investor as defined in one or more of the other categories/paragraphs numbered herein.

6) Irrevocable Trust. A trust (other than an ERISA plan) that (a)is not revocable by its grantors, (b) has in excess of $5 million of assets, (c) was not formed for the specific purpose of acquiring an interest, and (d) is directed by a person who has such knowledge and experience in financial and business matters that such person is capable of evaluating the merits and risks of an investment in the Trust.

7) IRA or Similar Benefit Plan. An IRA, Keogh or similar benefit plan that covers only a single natural person who is an Accredited Investor, as defined in one or more of the other categories/paragraphs numbered herein.

8) Participant-Directed Employee Benefit Plan Account. A participant-directed employee benefit plan investing at the direction of, and for the account of, a participant who is an Accredited Investor, as that term is defined in one or more of the other categories/paragraphs numbered herein.

9) Other ERISA Plan. An employee benefit plan within the meaning of Title I of the ERISA Act other than a participant-directed plan with total assets in excess of $5 million or for which investment decisions (including the decision to purchase an interest) are made by a bank, registered investment adviser, savings and loan association, or insurance company.

10) Government Benefit Plan. A plan established and maintained by a state, municipality, or any agency of a state or municipality, for the benefit of its employees, with total assets in excess of $5 million.

11) Non-Profit Entity. An organization described in Section 501(c)(3) of the Internal Revenue Code, as amended, with total assets in excess of $5 million (including endowment, annuity and life income funds), as shown by the organization’s most recent audited financial statements.

12) A bank, as defined in Section 3(a)(2) of the Securities Act (whether acting for its own account or in a fiduciary capacity).

13) A savings and loan association or similar institution, as defined in Section 3(a)(5)(A) of the Securities Act (whether acting for its own account or in a fiduciary capacity).

14) A broker-dealer registered under the Exchange Act.

15) An insurance company, as defined in Section 2(13) of the Securities Act.

16) A “business development company,” as defined in Section 2(a)(48) of the Investment Company Act.

17) A small business investment company licensed under Section 301 (c) or (d) of the Small Business Investment Act of 1958.

18) A “private business development company” as defined in Section 202(a)(22) of the Advisers Act.

19) Executive Officer or Director. A natural person who is an executive officer, director or general partner of the Partnership or the General Partner, and is an Accredited Investor as that term is defined in one or more of the categories/paragraphs numbered herein.

20) Entity Owned Entirely By Accredited Investors. A corporation, partnership, private investment company or similar entity each of whose equity owners is a natural person who is an Accredited Investor, as that term is defined in one or more of the categories/paragraphs numbered herein.

Please read the notice above and check the box below to continue.

Singapore

168 Robinson Road,
Capital Tower, Singapore 068912
+65 3105 1295

Taiwan

5th Floor, No. 1-8, Section 5, Zhongxiao East Road, Taipei

Hong Kong

R91, 3rd Floor,
Eton Tower, 8 Hysan Ave.
Causeway Bay, Hong Kong
+852 3002 4462

Australia

44 Martin Place, Sydney 2000 Australia
+02 8319 3232

Indonesia

Millennium Centennial Center, 38th Floor, Jl. Jend. Sudirman Kav. 25
Jakarta 12920, Indonesia

Market Coverage